Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-17
DOI
10.1245/s10434-020-08576-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment
- (2019) Constance D. Lehman et al. JAMA Oncology
- The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
- (2019) E Shelley Hwang et al. BMJ Open
- Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma
- (2019) Leslie R. Lamb et al. ACADEMIC RADIOLOGY
- Deep learning analysis of breast MRIs for prediction of occult invasive disease in ductal carcinoma in situ
- (2019) Zhe Zhu et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Ductal Carcinoma In Situ: The Whole Truth
- (2018) Ujas Parikh et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery
- (2018) Mirna B. Podoll et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Are There Alternative Strategies for the Local Management of Ductal Carcinoma in Situ?
- (2018) Kelly J. Rosso et al. Surgical Oncology Clinics of North America
- Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features
- (2018) Bibo Shi et al. Journal of the American College of Radiology
- Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions
- (2017) Chieh-Yu Lin et al. MODERN PATHOLOGY
- Active Surveillance for DCIS: The Importance of Selection Criteria and Monitoring
- (2016) Lars J. Grimm et al. ANNALS OF SURGICAL ONCOLOGY
- Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
- (2016) Melissa Pilewskie et al. ANNALS OF SURGICAL ONCOLOGY
- Addressing overtreatment of screen detected DCIS; the LORIS trial
- (2015) Adele Francis et al. EUROPEAN JOURNAL OF CANCER
- Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study
- (2015) Lotte E. Elshof et al. EUROPEAN JOURNAL OF CANCER
- Ductal carcinomain situ- update on risk assessment and management
- (2015) Jia-Min B Pang et al. HISTOPATHOLOGY
- Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens
- (2015) Joann G. Elmore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis
- (2015) Marc D. Ryser et al. JNCI-Journal of the National Cancer Institute
- Ductal Carcinoma In Situ: Treatment Update and Current Trends
- (2015) Katrina B. Mitchell et al. Current Oncology Reports
- Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis
- (2015) Marc D. Ryser et al. JNCI-Journal of the National Cancer Institute
- Concordance between vacuum assisted biopsy and postoperative histology: Implications for the proposed Low Risk DCIS Trial (LORIS)
- (2013) S. Soumian et al. EJSO
- Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision
- (2012) Jisun Kim et al. BREAST
- Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: Experience of 733 cases
- (2012) Chiara Trentin et al. BREAST
- Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy
- (2012) Sophie Schulz et al. BREAST
- Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer
- (2012) J Bruce et al. BRITISH JOURNAL OF CANCER
- Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer
- (2011) Meagan E. Brennan et al. RADIOLOGY
- Accuracy of a Preoperative Model for Predicting Invasive Breast Cancer in Women with Ductal Carcinoma-in-situ on Vacuum-Assisted Core Needle Biopsy
- (2010) Nehmat Houssami et al. ANNALS OF SURGICAL ONCOLOGY
- Radiologic-Pathologic Correlation of Ductal Carcinoma in Situ
- (2010) Takayuki Yamada et al. RADIOGRAPHICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started